Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.63
-0.59 (-6.40%)
At close: Nov 5, 2025, 4:00 PM EST
8.72
+0.09 (1.04%)
Pre-market: Nov 6, 2025, 4:10 AM EST

Revenue by Product

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Biopharma
6.14B
Log In
Log In
Log In
Log In
Upgrade
Biopharma Growth
10.51%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic
644.90M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Growth
-3.79%
Log In
Log In
Log In
Log In
Upgrade
Bio Supplies
215.66M
Log In
Log In
Log In
Log In
Upgrade
Bio Supplies Growth
34.83%
Log In
Log In
Log In
Log In
Upgrade
Other
209.23M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
2.84%
Log In
Log In
Log In
Log In
Upgrade
Intersegments
-
Log In
Log In
Log In
Log In
Upgrade
Intersegments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hospital
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States and Canada
4.09B
Log In
Log In
Log In
Log In
Upgrade
United States and Canada Growth
4.82%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
1.58B
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
10.22%
Log In
Log In
Log In
Log In
Upgrade
Rest of European Union
1.12B
Log In
Log In
Log In
Log In
Upgrade
Rest of European Union Growth
25.22%
Log In
Log In
Log In
Log In
Upgrade
Spain
423.08M
Log In
Log In
Log In
Log In
Upgrade
Spain Growth
16.59%
Log In
Log In
Log In
Log In
Upgrade